Complement in Alzheimer's disease: opportunities for modulating protective and pathogenic events
The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Abstract
The complement system is a critical element of the innate immune system recognizing and killing, or targeting for destruction, otherwise pathogenic organisms. In addition to triggering the generation of a membranolytic complex, complement proteins interact with cell surface receptors to promote a local inflammatory response that contributes to the protection and healing of the host. Compelling evidence has been reported that in Alzheimer's Disease complement activation occurs in the brain, and that this contributes to the development of a local inflammatory state that is correlated with cognitive dysfunction. However, recent data suggest that at least some of the complement components have the ability to contribute to neuroprotective pathways. Thus, it is the balance of these seemingly competing events that influences the ultimate state of neuronal function. Knowledge of the unique molecular interactions that occur in the development of Alzheimer's Disease, the functional consequences of those interactions, and the proportional contribution of each element to this disorder, should facilitate the design of effective therapeutic strategies for this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Complement activation is elevated in human AD brain, especially in the presence of fibrillar amyloid plaques containing clusters of reactive microglia (8, 9, 11, 12)”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [12]
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Gene-expression profile of the ageing brain in mice
Lee, C.-K., Weindruch, R., & Prolla, T. A. (2000) · Nature Genetics · doi:10.1038/77046 · Cited by 1,055
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., Teter, B., Tran, T., Ubeda, O., Ashe, K. H., Frautschy, S. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 884
Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 708
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 679
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
Paresce, D. M., Ghosh, R. N., & Maxfield, F. R. (1996) · Neuron · doi:10.1016/s0896-6273(00)80187-7 · Cited by 663
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587
Lemere, C. A., Blusztajn, J. K., Yamaguchi, H., Wisniewski, T., Saido, T. C., & Selkoe, D. J. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0003 · Cited by 584
MUTANT GENES IN FAMILIAL ALZHEIMER'S DISEASE AND TRANSGENIC MODELS
Price, D. L., & Sisodia, S. S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.479 · Cited by 572
A Prospective Study of Alzheimer Disease in Down Syndrome
Lai, F., & Williams, R. S. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520440031017 · Cited by 561
Buxbaum, J. D., Oishi, M., Chen, H. I., Pinkas-Kramarski, R., Jaffe, E. A., Gandy, S. E., & Greengard, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10075 · Cited by 559
T. Griffin, W. S., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 549
Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s2 · Cited by 519
The Classical Complement Pathway: Activation and Regulation of the First Complement Component
Cooper, N. R. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60340-5 · Cited by 510
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Macrophages and the Nervous System
Perry, V. H., & Gordon, S. (1991) · International Review of Cytology · doi:10.1016/s0074-7696(08)61220-6 · Cited by 428
Macrophages and inflammation in the central nervous system
Perry, V. H., Andersson, P.-B., & Gordon, S. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90180-t · Cited by 387
Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364
Combs, C. K., Johnson, D. E., Cannady, S. B., Lehman, T. M., & Landreth, G. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-03-00928.1999 · Cited by 352
Weldon, D. T., Rogers, S. D., Ghilardi, J. R., Finke, M. P., Cleary, J. P., O’Hare, E., Esler, W. P., Maggio, J. E., & Mantyh, P. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02161.1998 · Cited by 348
Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice
Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65423-5 · Cited by 345
Complement components of the innate immune system in health and disease in the CNS
Gasque, P., Dean, Y. D., McGreal, E. P., VanBeek, J., & Morgan, B. P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80302-1 · Cited by 343
Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330
Self-citationNeuronal Oxidative Stress Precedes Amyloid-β Deposition in Down Syndrome
Nunomura, A., Perry, G., Pappolla, M. A., Friedland, R. P., Hirai, K., Chiba, S., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.1011 · Cited by 320
Complement facilitates early prion pathogenesis
Klein, M. A., Kaeser, P. S., Schwarz, P., Weyd, H., Xenarios, I., Zinkernagel, R. M., Carroll, M. C., Verbeek, J. S., Botto, M., Walport, M. J., et al. (2001) · Nature Medicine · doi:10.1038/86567 · Cited by 318
Singhrao, S. K., Neal, J. W., Morgan, B. P., & Gasque, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7170 · Cited by 316
Neuronal Protection in Stroke by an sLe x -Glycosylated Complement Inhibitory Protein
Huang, J., Kim, L. J., Mealey, R., Marsh, H. C., Zhang, Y., Tenner, A. J., Connolly, E. S., & Pinsky, D. J. (1999) · Science · doi:10.1126/science.285.5427.595 · Cited by 315
Self-citationCummings, B. J., Pike, C. J., Shankle, R., & Cotman, C. W. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00170-4 · Cited by 305
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303
Self-citationLue, L. F., Brachova, L., CIVIN, W. H., & Rogers, J. (1996) · PubMed · Cited by 299
INTERACTION OF CELLS WITH IMMUNE COMPLEXES: ADHERENCE, RELEASE OF CONSTITUENTS, AND TISSUE INJURY
Henson, P. M. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.114 · Cited by 298
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
Specific Domains of β-Amyloid from Alzheimer Plaque Elicit Neuron Killing in Human Microglia
Giulian, D., Haverkamp, L. J., Yu, J. H., Karshin, W., Tom, D., Li, J., Kirkpatrick, J., Kuo, Y.-M., & Roher, A. E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06021.1996 · Cited by 271
Slow Degradation of Aggregates of the Alzheimer's Disease Amyloid β-Protein by Microglial Cells
Paresce, D. M., Chung, H., & Maxfield, F. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29390 · Cited by 271
Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A., & Van Eldik, L. J. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01318-8 · Cited by 262
Genetic Neurodegenerative Diseases: The Human Illness and Transgenic Models
Price, D. L., Sisodia, S. S., & Borchelt, D. R. (1998) · Science · doi:10.1126/science.282.5391.1079 · Cited by 259
Webster, S., Lue, L.-F., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258
Self-citationMastellos, D., Papadimitriou, J. C., Franchini, S., Tsonis, P. A., & Lambris, J. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2479 · Cited by 255
Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide
Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255
Nepomuceno, R. R., Henschen-Edman, A. H., Burgess, W. H., & Tenner, A. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80419-7 · Cited by 253
Self-citationThe neurobiologie consequences of down syndrome
Coyle, J. T., Oster-Granite, M. L., & Gearhart, J. D. (1986) · Brain Research Bulletin · doi:10.1016/0361-9230(86)90074-2 · Cited by 248
Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Molmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H., & Wetsel, R. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1861 · Cited by 247
Gasque, P., Singhrao, S. K., Neal, J. W., Götze, O., & Morgan, B. P. (1997) · Europe PMC (PubMed Central) · Cited by 234
Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J., & Pepys, M. B. (2001) · Nature Medicine · doi:10.1038/86562 · Cited by 224
Localization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Self-citationGowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., & Ball, M. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78080-6 · Cited by 223
Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester
Savage, M. J., Trusko, S. P., Howland, D. S., Pinsker, L. R., Mistretta, S., Reaume, A. G., Greenberg, B. D., Siman, R., & Scott, R. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01743.1998 · Cited by 213
Chemotaxis by a CNS macrophage, the microglia
Yao, J., Harvath, L., Gilbert, D. L., & Colton, C. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270106 · Cited by 211
Sellar, G. C., Blake, D. J., & Reid, K. B. (1991) · Biochemical Journal · doi:10.1042/bj2740481 · Cited by 210
Complement Biosynthesis in the Central Nervous System
Barnum, S. R. (1995) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411950060020301 · Cited by 207
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Lacy, M., Jones, J., Whittemore, S. R., Haviland, D. L., Wetsel, R. A., & Barnum, S. R. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00075-d · Cited by 200
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
Shen, Y., Li, R., McGeer, E. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 195
Association of an interleukin 1α polymorphism with Alzheimer’s disease
Du, Y., Dodel, R. C., Eastwood, B. J., Bales, K. R., Gao, F., Lohmüller, F., Müller, U., Kurz, A., Zimmer, R., Evans, R. M., et al. (2000) · Neurology · doi:10.1212/wnl.55.4.480 · Cited by 195
Kildsgaard, J., Hollmann, T. J., Matthews, K. W., Bian, K., Murad, F., & Wetsel, R. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5406 · Cited by 188
Stoltzner, S. E., Grenfell, T. J., Mori, C., Wisniewski, K. E., Wisniewski, T. M., Selkoe, D. J., & Lemere, C. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64753-0 · Cited by 187
Amyloid β protein (Aβ) removal by neuroglial cells in culture
Shaffer, L. M., Dority, M. D., Gupta-Bansal, R., Frederickson, R. C. A., Younkin, S. G., & Brunden, K. R. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00055-j · Cited by 182
Johnson, S. A., Lampert-Etchells, M., Pasinetti, G. M., Rozovsky, I., & Finch, C. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90086-d · Cited by 177
Frautschy, S. A., Cole, G. M., & Baird, A. (1992) · PubMed · Cited by 176
Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques
Ishii, T., & Haga, S. (1984) · Acta Neuropathologica · doi:10.1007/bf00687336 · Cited by 172
Veerhuis, R., Janssen, I., Groot, C. J. A. D., Muiswinkel, F. L. V., Hack, C. E., & Eikelenboom, P. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7199 · Cited by 171
Griffin, W. S. T., Sheng, J. G., Gentleman, S. M., Graham, D. I., Mrak, R. E., & Roberts, G. W. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90066-3 · Cited by 170
Ying, S. C., Gewurz, A. T., Jiang, H., & Gewurz, H. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.1.169 · Cited by 167
Complement anaphylatoxin receptors on neurons: new tricks for old receptors?
Nataf, S., Stahel, P. F., Davoust, N., & Barnum, S. R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01390-3 · Cited by 167
Giulian, D., Haverkamp, L. J., Yu, J., Karshin, W., Tom, D., Li, J., Kazanskaia, A., Kirkpatrick, J., & Roher, A. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29719 · Cited by 164
Velázquez, P., Cribbs, D. H., Poulos, T. L., & Tenner, A. J. (1997) · Nature Medicine · doi:10.1038/nm0197-77 · Cited by 158
Self-citationMouse strains with typical mammalian levels of complement activity
Ong, G. L., & Mattes, M. J. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90088-4 · Cited by 153
van Beek, J., Bernaudin, M., Petit, E., Gasque, P., Nouvelot, A., MacKenzie, E. T., & Fontaine, M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7273 · Cited by 151
Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment
O’Barr, S. A., Caguioa, J., Gruol, D., Perkins, G., Ember, J. A., Hugli, T., & Cooper, N. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4154 · Cited by 149
Dandoy-Dron, F., Guillo, F., Benboudjema, L., Deslys, J.-P., Lasmézas, C., Dormont, D., Tovey, M. G., & Dron, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7691 · Cited by 147
Haga, S., Ikeda, K., Sato, M., & Ishii, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91698-r · Cited by 146
Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
Sahu, A., & Lambris, J. D. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80299-4 · Cited by 144
Mechanisms of C5a and C3a Complement Fragment-Induced [Ca2+]iSignaling in Mouse Microglia
Möller, T., Nolte, C., Burger, R., Verkhratsky, A., & Kettenmann, H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-02-00615.1997 · Cited by 143
Neurons express proteins of the classical complement pathway in Alzheimer disease
Terai, K., Walker, D. G., McGeer, E. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00849-4 · Cited by 141
Sublytic complement attack induces cell cycle in oligodendrocytes
Rus, H. G., Niculescu, F., & Shin, M. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4892 · Cited by 139
Complement C1qB and C4 mRNAs responses to lesioning in rat brain
Pasinetti, G. M., Johnson, S. A., Rozovsky, I., Lampert-Etchells, M., Morgan, D., Gordon, M. N., Morgan, T. E., Willoughby, D., & Finch, C. E. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90028-o · Cited by 138
Complement Component C1q Modulates the Phagocytosis of Aβ by Microglia
Webster, S. D., Yang, A. J., Margol, L., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7260 · Cited by 138
Self-citationComplement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity
Osaka, H., Mukherjee, P., Aisen, P. S., & Pasinetti, G. M. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990601)73:3<303::aid-jcb2>3.0.co;2-2 · Cited by 136
Singhrao, S. K., Neal, J., Rushmere, N. K., Morgan, B. P., & Gasque, P. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64604-4 · Cited by 134
Bensa, J. C., Reboul, A., & Colomb, M. G. (1983) · Biochemical Journal · doi:10.1042/bj2160385 · Cited by 128
Detection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain
Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 125
Araujo, D. M., & Lapchak, P. A. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90398-0 · Cited by 120
Guan, E., Robinson, S. L., Goodman, E. B., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.4005 · Cited by 119
Self-citationPangburn, M. K., Pangburn, K. L. W., Koistinen, V., Meri, S., & Sharma, A. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4742 · Cited by 119
The Lectin Pathway of the Complement System
Matsushita, M. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01156.x · Cited by 118
Characterization of interleukin-1 production by microglia in culture
Yao, J., Keri, J. E., Taffs, R. E., & Colton, C. A. (1992) · Brain Research · doi:10.1016/0006-8993(92)90981-e · Cited by 118
Microglia, an in vivo source of reactive oxygen species in the brain.
Colton, C. A., & Gilbert, D. L. (1993) · PubMed · Cited by 113
Soane, L., Rus, H., Niculescu, F., & Shin, M. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6132 · Cited by 112
Membrane receptors for soluble defense collagens
Tenner, A. J. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80007-7 · Cited by 109
Self-citationJiang, H., Robey, F. A., & Gewurz, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1373 · Cited by 106
Webster, S. D., Galvan, M. D., Ferran, E., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7496 · Cited by 105
Self-citationHead, E., Azizeh, B. Y., Lott, I. T., Tenner, A. J., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0380 · Cited by 103
Self-citationAggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide
Webster, S., Bradt, B., Rogers, J., & Cooper, N. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010388.x · Cited by 103
Dietzschold, B., Schwaeble, W., Schäfer, M. K. H., Hooper, D. C., Zehng, Y. M., Petry, F., Sheng, H., Fink, T., Loos, M., Koprowski, H., et al. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00269-t · Cited by 102
C1q—how many functions? How many receptors?
Eggleton, P., Reid, K. B. M., & Tenner, A. J. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01373-7 · Cited by 93
Microorganisms and their interaction with the immune system
Kotwal, G. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.4.415 · Cited by 91
Complement activation and β-amyloid-mediated neurotoxicity in Alzheimer's disease
Rogers, J., Schultz, J., Brachova, L., Lue, L. F., Webster, S. M., Bradt, B. M., Cooper, N. R., & Moss, D. E. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80046-n · Cited by 90
Enhanced expression of chemotactic receptors in multiple sclerosis lesions
Müller‐Ladner, U., Jones, J. L., Wetsel, R. A., Gay, S., Raine, C. S., & Barnum, S. R. (1996) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00217-1 · Cited by 84
Webster, S., Glabe, C., & Rogers, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2852 · Cited by 84
Adayev, T., Estephan, R., Meserole, S., Mazza, B., Yurkow, E. J., & Banerjee, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71051854.x · Cited by 80
Senile plaques do not progressively accumulate with normal aging
Mackenzie, I. R. (1994) · Acta Neuropathologica · doi:10.1007/bf00294179 · Cited by 75
Pasinetti, G. M., Tocco, G., Sakhi, S., Musleh, W. D., Simoni, M. G. D., Mascarucci, P., Schreiber, S., Baudry, M., & Finch, C. E. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0020 · Cited by 75
Nonimmune activation of the classical complement pathway.
Gewurz, H., Ying, S.-C., Jiang, H., & Lint, T. F. (1993) · PubMed · Cited by 75
Chen, S., Frederickson, R. C. A., & Brunden, K. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00103-0 · Cited by 73
O’Barr, S. A., & Cooper, N. R. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00291-5 · Cited by 69
Tenner, A. J., & Volkin, D. B. (1986) · Biochemical Journal · doi:10.1042/bj2330451 · Cited by 65
Self-citationComplement proteins and complement inhibitors in Alzheimer's disease
McGeer, P. L., & McGeer, E. G. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80045-m · Cited by 57
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65489-2 · Cited by 49
The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation☆
Webster, S. D., Tenner, A. J., Poulos, T. L., & Cribbs, D. H. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00020-2 · Cited by 49
Self-citationBarnum, S. R. (1999) · Molecular Medicine · doi:10.1007/bf03402070 · Cited by 48
Microglia in Alzheimer's Disease and Transgenic Models
Dickson, D. W. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65416-8 · Cited by 46
Monocyte‐mediated entry of pathogens into the central nervous system
WILLIAMS, A. E., & BLAKEMORE, W. F. (1990) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1990.tb01274.x · Cited by 43
Daly, J. J., & Kotwal, G. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00100-6 · Cited by 40
BERGAMASCHINI, L., CANZIANI, S., BOTTASSO, B., CUGNO, M., BRAIDOTTI, P., & AGOSTONI, A. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00835.x · Cited by 39
The complement attack phase: control of lysis and non-lethal effects of C5b-9
Hänsch, G. M. (1992) · Immunopharmacology · doi:10.1016/0162-3109(92)90017-7 · Cited by 35
Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
Cooper, N. R., & Ziccardi, R. J. (1977) · PubMed · Cited by 32
Chu, T., Tran, T., Yang, F., Beech, W., Cole, G. M., & Frautschy, S. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01161-2 · Cited by 29
Characterization of neuronal cell death induced by complement activation
Shen, Y., Halperin, J. A., Benzaquen, L. R., & Lee, C. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(96)00026-8 · Cited by 26
CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells
Sawant‐Mane, S., Piddlesden, S. J., Morgan, B. P., Holers, V. M., & Koski, C. L. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00048-3 · Cited by 26
Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes
Wang, C., Gerard, N. P., & Nicholson-Weller, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.786 · Cited by 17
C1 activation by amyloid β fibrils. Evidence for a binding site for Aβ on the C1q globular regions
Tacnet‐Delorme, P., Galvan, M. D., Chevallier, S., Glabe, C. G., Tenner, A. J., & Arlaud, G. J. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)80039-9 · Cited by 1
Self-citationArd (1996) · doi:10.1002/(sici)1097-4547(19960115)43:2
Cited by
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
“Moreover, there is an extensive literature demonstrating that the complement system also has a neuroprotective role in neuroinflammation [59, 60, 71, 74].”
BackgroundComplement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593
“Complement activation is elevated in human AD brain, especially in the presence of fibrillar amyloid plaques containing clusters of reactivemicroglia (8, 9, 11, 12) and in the brains of AD amyloidosis mouse models (10, 17, 31).”
BackgroundCribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499
Self-citationSalminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 346
Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease
Fonseca, M. I., Zhou, J., Botto, M., & Tenner, A. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0901-04.2004 · Cited by 345
“, 2002), suggesting that complement could also be neuroprotective (Tenner, 2001; Wyss-Coray and Mucke, 2002).”
BackgroundSelf-citation
Metadata
- Authors
- Tenner, A.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Tenner, A
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 22
- Issue
- 6
- Pages
- 849-861
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2138150745
- Cited by
- 81
- References
- 136
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 4 · 2018: 3 · 2017: 1 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 6
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (P50 AG 16573, P50AG016573)
- National Institute of Neurological Disorders and Stroke (R01NS035144, NS35144)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- complement system, Alzheimer's disease, complement activation, neuroinflammation, neuroprotection, cognitive impairment, complement receptors, treatment options, innate immunity
- MeSH terms
- Alzheimer Disease, Cognition Disorders, Complement System Proteins, Complement Activation, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.